Bio-Techne dividend
MyStockButler's October 2026 analysis: Bio-Techne pays $0.32 per share annually through FY2026. Bio-Techne generated $263.223 million of free cash flow in FY2026 and paid $91.591 million to shareholders.
How much does Bio-Techne pay per share?
The bear case uses $0.32 per share at each date because Bio-Techne paid that annual amount consistently through FY2026 and generated strong free cash flow. The Wilson Wolf obligation remains a reason not to treat that continuation as certain.
| Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | |
|---|---|---|---|---|---|
| Revenue | 1,215,039 | 1,219,635 | 1,159,060 | 1,136,702 | 1,105,599 |
| Net income | 181,862 | 73,400 | 168,105 | 285,263 | 272,051 |
| EPS, diluted | 1.16 | 0.46 | 1.05 | 1.76 | 1.66 |
| Dividend per share | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
What this means. The sales growth percentages include acquisitions, businesses sold, and currency changes, so they do not show how much the existing business grew on its own.
How much would Bio-Techne's dividend pay you?
$10,000 invested in Bio-Techne at its 0.4% dividend yield (our report of October 25, 2026) pays $40.00 in the first year, before tax. If its dividend per share keeps changing 0.8% a year, as it did from Jun 2022 to Jun 2026, and the dividends are reinvested, year 10 pays $44.59, with $422.48 received in all.
Before tax. Past dividend growth is not a promise. Information only, not investment advice.
Is Bio-Techne’s dividend covered by its cash?
Fiscal 2026 restored some financial room. Free cash flow reached $263.223 million, while shareholder payments fell to $91.591 million. Cash and short-term investments ended at $264.712 million against total debt of $200.000 million, producing $64.712 million of net cash. But the credit facility matures on August 31, 2027, before the Wilson Wolf purchase deadline. The earlier buybacks therefore matter because they used capacity that could have helped fund or refinance that obligation.
| Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | |
|---|---|---|---|---|---|
| Free cash flow | 263,223 | 256,550 | 236,104 | 216,149 | 280,364 |
| − Dividends paid | 49,916 | 50,391 | 50,419 | 50,285 | 50,185 |
| − Share buybacks | 41,675 | 275,731 | 80,042 | 19,562 | 160,950 |
| Paid to shareholders | 91,591 | 326,122 | 130,461 | 69,847 | 211,135 |
What this means. The company paid shareholders more than the cash it made in 2025, so it had to use savings or borrow money to cover the difference.
What could change Bio-Techne’s dividend?
The dividend row follows the transaction timing. Base and bull cases use $0.16 per share at the first date, then zero. That reflects two regular quarterly payments before closing and no later TECH dividend.
| October 2027 | October 2028 | October 2029 | |
|---|---|---|---|
| Earnings | 373 (300 / 400) | 395 (290 / 445) | 417 (295 / 493) |
| Dividends per share | 0.16 (0.32 / 0.16) | 0.00 (0.32 / 0.00) | 0.00 (0.32 / 0.00) |
| Price to earnings | 30.70 (22.00 / 31.40) | 29.00 (20.00 / 31.80) | 27.50 (19.00 / 32.00) |
What is Bio-Techne’s dividend yield today?
Free cash flow yield is 2.3%, while dividend yield is 0.4%. The modest cash return means repeat laboratory demand matters as much as accounting profit, which makes the company’s history the next test.